It is not permitted to submit work that has been published and/or is likely to be published before the Abstract Submission Deadline (31st Aug 2025). The Programme Committee has the right to remove an abstract if it contains data that has already been published. However, DAISICON 2025 accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings.

Abstracts submitted on Human Studies:
The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration

Abstracts submitted on Animal Studies:
The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.

The abstract must be submitted as follows:
There is no limit to the number of abstracts an author may submit; however, an author may only serve as the presenting author on two submissions. It is the authors’ responsibility to designate a new presenter for presentation scheduling conflicts that arise. If accepted, the presenter must be a co-author listed on the abstract at the time of submission.
The abstract must be submitted in English.

Your abstract submission must adhere to the following structure:
• The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 170 characters).
• The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims:, Materials and methods:, Results: and Conclusion:).
• For drugs exclusively generic names should be used (no trademarks).
• Grant/Support information must be entered.
• Where applicable, the Clinical Trial Registration Number must be entered into its designated field; not in the abstract body.
• Registration for the conference is mandatory for abstract submission.
• Abstracts should be submitted as an email attachment along with their DAISICON 2025 Registration details.

Once all submission steps have been successfully completed and the abstract deadline has passed, the presenting author will receive a notification in email confirming the final version of the abstract submission.

In case of questions, or if you have not received a notification confirming the final version of the abstract submission by 2nd Sep 2025, please contact the DAISICON 2025 office: daisicon2025abstract@gmail.com